European Union announces new programme to improve Parkinson’s diagnosis

News

Author: Parkinson's Life editorsPublished: 17 January 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

PD-Podcast-DBS

The European Union has announced the launch of the Magnetic Diagnostic Assay for Neurodegenerative Diseases (MADIA) – a project with the ultimate goal of improving diagnosis for those living with Parkinson’s and Alzheimer’s.

The project, which is in partnership with a range of international universities and institutions, will focus on the development of a novel device that will help clinicians perform a simple click and analysis to diagnose both conditions.

Dr Francisco Campos, of the Clinical Neurosciences Research Laboratory, said: “An early diagnosis is crucial to maximise the effectiveness of the treatments in order to mitigate the devastating effects of these illnesses and slow disease progression.

“MADIA is funded by the European Union’s Horizon 2020 research and innovation programme, and consists of a multitasking team with more than 50 professionals in the fields of biology, physics and engineering.”

For comprehensive information about Parkinson’s diagnosis please visit Parkinson’s Europe website.

Go Back

Share this story

Comments


Related articles


2 year old with PD lead

Perspectives

Two-year-old could be world’s youngest person diagnosed with Parkinson’s

Toddler diagnosed with juvenile Parkinson’s disease with dystonia

READ MORE
Michael J Fox Donald Trump

Perspectives

Michael J Fox hopes Trump government will continue support for Parkinson’s research

Will the Trump administration support Parkinson’s research?

READ MORE
Senior woman sitting alone on a chair at home

Special reports

Ask the expert: How can hallucinations affect people with Parkinson’s?

Professor Per Odin shares need-to-know information on the symptom

READ MORE